Major finding: F1174L-mutated ALK shows reduced sensitivity to crizotinib inhibition.

Mechanism: The F1174L mutation enhances the ATP-binding affinity of ALK.

Impact: Patients with F1174L-mutated ALK may benefit from higher crizotinib doses.

This content is only available via PDF.